Evidence map›Paper›PMID 25889857›Full record

ArticleJournal of translational medicine2015

Conditioned media from adipose stromal cells limit lipopolysaccharide-induced lung injury, endothelial hyperpermeability and apoptosis.

Hongyan Lu, Christophe Poirier, Todd Cook, Dmitry O Traktuev, Stephanie Merfeld-Clauss, Benjamin Lease, Irina Petrache, Keith L March, Natalia V Bogatcheva

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Therapeutic Use of Adipose-Derived Stromal Cells in a Murine Model of Acute Pancreatitis.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2020
    Article
  11. Article
  12. EMAPII Monoclonal Antibody Ameliorates Influenza A Virus-Induced Lung Injury.Molecular therapy : the journal of the American Society of Gene Therapy · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Hongyan LuDivision of Cardiology, Indiana University, Indianapolis, IN, USA. honlu@iu.edu.
Christophe PoirierDivision of Pulmonary and Critical Care Medicine, Indiana University, Indianapolis, IN, USA. poirierc@iu.edu.
Todd CookDivision of Cardiology, Indiana University, Indianapolis, IN, USA. tgcook@iu.edu.
Dmitry O TraktuevDivision of Cardiology, Indiana University, Indianapolis, IN, USA. tdmitry@iu.edu.
Stephanie Merfeld-ClaussDivision of Cardiology, Indiana University, Indianapolis, IN, USA. smerfeld@iu.edu.
Benjamin LeaseIndiana Center for Vascular Biology and Medicine and VC-CAST Signature Center, Indianapolis, IN, USA. benlease@iupui.edu.
Irina PetracheIndiana Center for Vascular Biology and Medicine and VC-CAST Signature Center, Indianapolis, IN, USA. ipetrach@iu.edu.
Keith L MarchDivision of Cardiology, Indiana University, Indianapolis, IN, USA. kmarch@iu.edu.
Natalia V BogatchevaDivision of Cardiology, Indiana University, Indianapolis, IN, USA. nbogatch@iu.edu.
Indiana University – Purdue University Indianapolis · US

Funding

Direct and Bone-Marrow Mediated Effects of Adipose Stem Cells in EmphysemaR01HL105772 · NHLBI · NATIONAL JEWISH HEALTH · PI MARCH, KEITH LEONARD, PETRACHE, IRINA · 2012 to 2015
$1.5M
NHLBI NIH HHS R01 HL105772
6 · The paper itself

Abstract

backgroundAcute Respiratory Distress Syndrome (ARDS) is a condition that contributes to morbidity and mortality of critically ill patients. We investigated whether factors secreted by adipose stromal cells (ASC) into conditioned media (ASC-CM) will effectively decrease lung injury in the model of lipopolysaccharide (LPS)-induced ARDS.

methodsTo assess the effect of ASC-CM on ARDS indices, intravenous delivery of ASC and ASC-CM to C57Bl/6 mice was carried out 4 h after LPS oropharyngeal aspiration; Evans Blue Dye (EBD) was injected intravenously 1 h prior to animal sacrifice (48 h post-LPS). Lungs were either fixed for histopathology, or used to extract bronchoalveolar lavage fluid (BALF) or EBD. To assess the effect of ASC-CM on endothelial barrier function and apoptosis, human pulmonary artery endothelial cells were treated with ASC-CM for 48-72 h.

resultsASC-CM markedly reduced LPS-induced histopathologic changes of lung, protein extravasation into BALF, and suppressed the secretion of proinflammatory cytokines TNFα and IL6. White Blood Cells (WBC) from BALF of LPS-challenged mice receiving ASC-CM had decreased reactive oxygen species (ROS) generation compared to WBC from LPS-challenged mice receiving control media injection. Treatment of pulmonary endothelial monolayers with ASC-CM significantly suppressed H2O2-induced leakage of FITC dextran and changes in transendothelial resistance, as well as gap formation in endothelial monolayer. ASC-CM exposure reduced the percentage of endothelial cells expressing ICAM-1, and suppressed TNFα-induced expression of E-selectin and cleavage of caspase-3. ASC-CM reduced the endothelial level of pro-apoptotic protein Bim, but did not affect the level of Bcl-2, Bad, or Bad phosphorylation.

conclusionsFactors secreted by ASC efficiently reduce ARDS indices, endothelial barrier hyperpermeability, and activation of pro-inflammatory and pro-apoptotic pathways in endothelium.

Indexed as

Acute Lung InjuryAdipose TissueAnimalsApoptosisBiomarkersBronchoalveolar Lavage FluidCell Membrane PermeabilityCulture Media, ConditionedCytokinesEndothelial CellsE-SelectinFlow CytometryHumansInflammation MediatorsIntercellular Adhesion Molecule-1Leukocyte CountBiomarkersCulture Media, ConditionedCytokinesE-SelectinInflammation MediatorsIntercellular Adhesion Molecule-1LipopolysaccharidesSELE protein, human

Identifiers

PMID25889857
PMCPMC4358867
OpenAlexW2118692062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.